Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Cabaletta Bio, Inc. (CABA)

NASDAQ

$2,97

$--

(0,00%)

Cabaletta Bio, Inc. (CABA) Live Price Chart

Page last updated: 2026-04-06 11:16:00

Key Market Data

Market Cap	$330,18M
Open	$2,94
High	$26,35
Low	$0,59
Previous Close	--
Price Change	--
Percentage Change	0,00%
Volume	4K

Cabaletta Bio, Inc. (CABA) Stock Price Today

Cabaletta Bio, Inc. (CABA) is currently trading at $2,97 as of 2026-04-06 11:16:00, reflecting a 0,00% move ($-0,00) from the previous close.

In the short term, the stock has returned -9,30% over the past four weeks. Over the last 12 months, Cabaletta Bio, Inc. has recorded a +159,04% price change, indicating a strong performance relative to the broader market.

Cabaletta Bio, Inc. (CABA) 7-Day Stock Price Changes

Over the past seven days, Cabaletta Bio, Inc. has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $2,50 to the latest recorded price of $2,97, reflecting an intraday change of 0,00%. Daily movements highlight shifts in trading volume (4 377), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, CABA has delivered a -9,30% return over the past month and a +159,04% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy Cabaletta Bio, Inc. (CABA)

You can buy and trade CABA on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for CABA and Execute Your Trade

Open the trading page, enter CABA in the search bar, select the amount of CABA you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Cabaletta Bio, Inc. (CABA)?

Cabaletta Bio Inc is a late clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Its proprietary Cabaletta Approach to B cell Ablation (CABA) platform includes the CARTA approach, which uses chimeric antigen receptor T cells to eliminate B cells and potentially reset the immune system. The company develops cellular therapies including CAR T and CAAR T product candidates. Its candidate, rese-cel (resecabtagene autoleucel), a CD19-CAR T cell therapy, is being evaluated in Phase 1/2 trials for autoimmune diseases such as systemic lupus erythematosus, myositis, systemic sclerosis, generalized myasthenia gravis, and pemphigus vulgaris.

Cabaletta Bio, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	156
Sector	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Company Website	https://www.cabalettabio.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Cabaletta Bio, Inc.?

The latest trading price for Cabaletta Bio, Inc. (Common Stock) is $ 2,97, compared with a previous closing price of --. That means the stock has moved 0,00% so far today. Intraday price updates and recent trading activity for CABA can be tracked on the live chart and quote section on this page.

2.Is Cabaletta Bio, Inc. stock going up or down?

Looking at recent performances, CABA has returned -9,30% over the past month, +4,07% over the last six months and +159,04% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for Cabaletta Bio, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does CABA currently sit relative to its 52-week high and low?

In the most recent 52-week period, Cabaletta Bio, Inc. has traded between a low of $ 0,99 and a high of $ 3,78. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether CABA is currently nearer the top or the bottom of its one-year trading band.

4.How is Cabaletta Bio, Inc. classified by sector and industry?

Cabaletta Bio, Inc. is classified in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. In practice, this means Cabaletta Bio, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing CABA’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector could influence Cabaletta Bio, Inc.’s performance.

5.Where is Cabaletta Bio, Inc. listed and how large is it by market value?

Cabaletta Bio, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 330,18M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Cabaletta Bio, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does CABA's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -1,51 summarises how much profit Cabaletta Bio, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Cabaletta Bio, Inc.'s financial performance over time?

To follow Cabaletta Bio, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how CABA is performing and how the market is responding.

8.When is Cabaletta Bio, Inc. expected to report earnings?

Cabaletta Bio, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for CABA, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Cabaletta Bio, Inc.'s earnings reports?

Cabaletta Bio, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether CABA is meeting, beating or missing expectations.

10.How can I stay informed about Cabaletta Bio, Inc.'s results and guidance?

You can stay up to date on Cabaletta Bio, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for CABA on this page helps you see how new information is being reflected in the stock.

11.Does Cabaletta Bio, Inc. pay a regular cash dividend to its shareholders?

Cabaletta Bio, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor CABA's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for CABA?

Based on the latest earnings data, CABA has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Cabaletta Bio, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Cabaletta Bio, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Cabaletta Bio, Inc.?

Cabaletta Bio, Inc. is a publicly traded company in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry within the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is CABA valued in terms of P/E ratio and EPS?

Cabaletta Bio, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -1,51. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Cabaletta Bio, Inc.'s earnings. Comparing CABA's P/E and EPS to those of other BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Cabaletta Bio, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

CAT

FLR

Top Gainers

Browse today's leading gainers in the US stock market

Alight, Inc.

ALIT

Abercrombie & Fitch Co.

ANF

Annovis Bio, Inc.

ANVS

GCT Semiconductor Holding, Inc.

GCTS

Lifezone Metals Limited

LZM

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

CABA-to-USD Calculator

Amount

CABA

USD

1 CABA = 2,966 USD